A new drug review for vericiguat, indicated for heart failure, reports efficacy and safety data.
Katelyn Yamartino, PharmD
Advertisement
Articles by Katelyn Yamartino, PharmD
An overview of the use of satralizumab-mwge (Enspryng; Genentech) in neuromyelitis optica spectrum disorder (NMOSD).
Advertisement
Latest Updated Articles
Satralizumab-mwge for Neuromyelitis Optica Spectrum Disorder in AdultsNovember 11th 2020
Advertisement
Advertisement
Trending on Drug Topics
1
FDA Approves First At-Home Starting Dose for Leqembi in Early Alzheimer Disease
2
Retail Closures Threaten Pharmacy Access in Vulnerable Communities
3
Q&A: How AI Is Reshaping the Pharmacist's Role in Medication Safety
4
Emerging Market Access Models Reshapes Drug Distribution
5